Michael Green, PhD, discusses a new method of assessing lymphoma subtypes utilizing the tumor microenvironment.
Michael Green, PhD
Advertisement
Michael Green, PhD, is an associate professor of lymphoma/myeloma at The University of Texas MD Anderson Cancer Center in Houston, TX.
Articles by Michael Green, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
Safusidenib Shows Robust, Ongoing Responses in Grade 2 IDH1-Mutant Glioma
4
Sac-TMT Demonstrates Antitumor Activity, Safety in Urothelial Carcinoma
5
